Nepa AB (publ) (STO:NEPA)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	160	149	226	294	689	311
Market Cap Growth	-33.86%	-33.80%	-23.26%	-57.31%	121.21%	80.00%
Enterprise Value	116	120	184	232	610	257
Last Close Price	20.30	17.78	25.63	31.38	72.19	32.63
PE Ratio	-	-	-	16.82	17.85	23.71
PS Ratio	0.61	0.55	0.72	0.87	2.25	1.17
PB Ratio	2.61	2.00	2.61	2.68	6.70	4.79
P/TBV Ratio	2.61	2.00	2.61	2.68	6.70	4.79
P/FCF Ratio	15.38	9.83	37.21	18.90	27.00	4.88
P/OCF Ratio	15.30	9.79	37.06	18.50	26.36	4.87
EV/Sales Ratio	0.44	0.44	0.58	0.68	1.99	0.96
EV/EBITDA Ratio	-	-	-	14.91	16.74	23.42
EV/EBIT Ratio	-	-	-	15.21	16.85	24.09
EV/FCF Ratio	11.13	7.87	30.31	14.88	23.92	4.03
Asset Turnover	1.80	1.61	1.61	1.66	1.68	1.77
Quick Ratio	1.12	1.29	1.19	1.51	1.72	1.26
Current Ratio	1.34	1.38	1.32	1.60	1.75	1.32
Return on Equity (ROE)	-21.92%	-2.15%	-14.67%	16.46%	45.97%	22.73%
Return on Assets (ROA)	-7.79%	-2.64%	-6.17%	4.67%	12.44%	4.42%
Return on Capital (ROIC)	-15.34%	-5.52%	-12.29%	8.96%	26.97%	11.53%
Return on Capital Employed (ROCE)	-	-	-	13.90%	35.20%	16.40%
Earnings Yield	-10.08%	-1.16%	-6.38%	5.95%	5.60%	4.22%
FCF Yield	6.50%	10.17%	2.69%	5.29%	3.70%	20.48%
Dividend Yield	6.17%	6.92%	4.80%	1.79%	1.70%	-
Payout Ratio	-	-	-	55.31%	-	-
Buyback Yield / Dilution	-0.26%	-0.26%	0.15%	-0.24%	0.06%	0.02%
Total Shareholder Return	5.93%	6.65%	4.95%	1.54%	1.76%	0.02%

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.